Effects of dextranation on the uptake of peptides in micrometastases: Studies on binding of EGF in tumor spheroids

Tumor Biology

Volumn 22, Issue 4, 2001, Pages 229-238

  Nilsson, Per ^a   Gedda, Lars ^a   Sjöström, Anna ^a   Carlsson, Jörgen ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Dextran; EGF; Glioma cells; Micrometastasis; Spheroids; Therapy, targeted

Indexed keywords

DEXTRAN; EPIDERMAL GROWTH FACTOR; IODINE 125; PENTETIC ACID; PEPTIDE;

ARTICLE; CONJUGATE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PROTEIN BINDING; GLIOMA CELL; HUMAN; HUMAN CELL; HYDROPHILICITY; ISOELECTRIC POINT; ISOTOPE LABELING; METASTASIS; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BINDING; TUMOR SPHEROID;

EID: 0034954310     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050621     Document Type: Article

References (40)

1. Radionuclide therapy
2. Strategies for developing effective radioimmunotherapy for solid tumors
3. Receptor targeting for tumor localisation and therapy with radiopeptides
4. 131I conjugates on the clonogenic survival of cultured glioma cells
5. Selective killing of tumor cells using EGF or TGF alpha-pseudomonas exotoxin chimeric molecules
6. Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor receptor
7. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors
8. Boron neutron capture therapy of brain tumors: An emerging therapeutic modality
9. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF
10. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin
11. Gene amplification in malignant human gliomas: Clinical and histopathologic aspects
12. Gene and chromosomal alterations associated with the development of human glioma
13. The receptor for EGF and its ligands: Expression, prognostic value and target for therapy in cancer
14. Binding of epidermal growth factor-dextran conjugates to cultured glioma cells
15. Effects of epidermal growth factor receptor blocking in cultured glioma spheroids
16. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells
17. Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells
18. EGF induces cell-cycle arrest of A431 human epidermoid carcinoma cells
19. Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured human squamous-carcinoma cells
20. Binding, internalization and degradation of EGF-dextran conjugates in two human bladder cancer cell lines
21. Structure-function relationships in epidermal growth factor (EGF) and transforming growth factor-α (TGF-α)
22. Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF
23. Cell and environment interactions in tumor microregions: The multicell spheroid model
24. The influence of microenvironmental factors during cancer therapy
25. Multicellular spheroids as an in vitro tumor model
26. Multicellular spheroids: A three-dimensional in vitro culture system to study tumor biology
27. Three-dimensional spheroid model in tumor biology
28. Three-dimensional cell cultures: From molecular mechanisms to clinical applications
29. Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma origin
30. Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy
31. Preparation of sulfhydrylborane-dextran conjugates for boron neutron capture therapy
32. Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells
33. Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines
34. The non-variation in radiosensitivity of different proliferative states of human glioma cells
35. Differential penetration of targeting agents into multicellular spheroids derived from human neuroblastoma
36. 90Y
37. 131I-labeled E4 antibodies on cells at different depths in DU-145 spheroids
38. Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At] astato-3-pyridinecarboxylate
39. An analysis of monoclonal antibody distribution in microscopic tumor nodules: Consequences of a 'binding site barrier'
40. Early intervention in cancer using monoclonal antibodies and other biological ligands: Micropharmacology and the 'binding site barrier'